In this regulation, PPARγ, a nuclear receptor highly expressed in adipose tissue was upregulated and activated in patients with MASLD in association with increased H19 and downregulation of miR-130a. This evidence concerns the gene H19 and metabolic dysfunction-associated steatotic liver disease.